ZAP-X Stereotactic Radiosurgery Initial Patient Experience

This document is a research article detailing the initial experience of using the ZAP-X stereotactic radiosurgery (SRS) platform involving 200 patients treated for various intracranial targets. The study, conducted at Jersey Shore University Medical Center, aimed to evaluate the feasibility, safety, clinical and dosimetric performance, and patient satisfaction associated with the ZAP-X system. The cohort included patients with conditions such as brain metastases, meningiomas, and trigeminal neuralgias, among others. Key findings include an average gamma passing rate of 98.5% and high patient satisfaction scores. The ZAP-X system demonstrated advantages in treatment time and patient comfort compared to traditional SRS platforms. The article outlines the clinical workflow, treatment planning processes, and quality assurance measures implemented during the study. It emphasizes the importance of continued research to validate these findings and assess long-term outcomes, marking this as a significant contribution to the field of radiation oncology.